key: cord-0960763-k0te068l
authors: Mao, Ren; Liang, Jie; Shen, Jun; Ghosh, Subrata; Zhu, Liang-Ru; Yang, Hong; Wu, Kai-Chun; Chen, Min-Hu
title: Implications of COVID-19 for patients with pre-existing digestive diseases
date: 2020-03-11
journal: Lancet Gastroenterol Hepatol
DOI: 10.1016/s2468-1253(20)30076-5
sha: e1c4cb9955806b21950e45febde81d0eca3a5b3e
doc_id: 960763
cord_uid: k0te068l

nan

C o V -2 仍 不 清 楚 。 在 最 近 中 国 癌 症 患 者 感 染 SARS-CoV-2的分析中 7 ， 1590例COVID-19中有 18例(1%)有肿瘤史, 其中3例结直肠癌病史( 结肠管状腺癌1例，直肠癌1例，结直肠癌1例) 。 7 目前数据显示合并肿瘤的COVID-19的患者预 后更差。因此建议，在患者个体化治疗基础上推 迟辅助化疗或择期手术，加强个人防护措施，以 及更严密的监控或治疗。 7 生物制剂和免疫抑制剂的使用，是否使IBD患 者更易感染SARS-CoV-2是普遍关注的问题。目 前，在包括中国最 大的7个IBD转诊中心，拥有 表1. COVID-

First case of 2019 novel coronavirus in the United States

Clinical characteristics of coronavirus disease 2019 in China

Macroscopic autopsy findings in a patient with COVID-19

Liver injury in COVID-19: management and challenges

Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening

COVID-19) for transplant clinicians

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Networked Clinical study collaboration on inflammatory bowel disease in China

Chinse Society of IBD. Managing IBD patients during the outbreak of COVID-19

Crohn's Colitis Foundation. What IBD patients should know about the 2019 novel coronavirus

Crohn's & Colitis UK. Novel coronavirus (COVID-19) advice